Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Cardiotoxicity 5 Sarcoma 3 Lymphoma 3 Sarcoma, Synovial 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Localized Extraskeletal Ewing Sarcoma 1 Liposarcoma 1 Leukemia 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Ganglioneuroblastoma 1 Fibrosarcoma 1 Extravasation 1 Dermatofibrosarcoma 1 Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 227 Cytarabine 194 fludarabine phosphate 138 Methotrexate 132 Filgrastim 127 Busulfan 103 Etoposide 99 Peripheral Blood Stem Cell Transplantation 91 Rituximab 81 fludarabine 77 Radiotherapy 77 Vincristine 74 Daunorubicin 68 Antilymphocyte Serum 65 Cyclosporine 63 Dexamethasone 61 Tacrolimus 56 Mycophenolic Acid 53 Melphalan 52 Imatinib Mesylate 50 Granulocyte Colony-Stimulating Factor 50 Mercaptopurine 46 Whole-Body Irradiation 45 Idarubicin 43 sargramostim 42 Methylprednisolone 42 Doxorubicin 41 Flow Cytometry 40 Prednisone 39 Clofarabine 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leukemia × Razoxane × Clear all

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡